The clinical role of procalcitonin in hematopoietic SCT
Open Access
- 20 February 2012
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 47 (10) , 1326-1331
Abstract
Infectious disease following hematopoietic SCT (HSCT) is a major cause of TRM. The more valuable markers to distinguish infections disease from non-infectious complications are needed. Procalcitonin (PCT) and C-reactive protein (CRP) were measured periodically throughout the clinical course of consecutive 28 patients who underwent HSCT. The diagnoses of 103 febrile episodes were analyzed. PCT and CRP level on the first day of fever significantly increased in systemic bacterial or fungal infection (PP=0.035). PCT provide additional information for discrimination between bacterial or fungal infection and other causes and predicting the patient’s prognosis after HSCT.Keywords
This publication has 28 references indexed in Scilit:
- The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious feverJournal of Infection, 2010
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract InfectionsJAMA, 2009
- Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Procalcitonin Guidance of Antibiotic Therapy in Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Evaluation of C‐reactive protein, interleukin‐6, and procalcitonin levels in allogeneic hematopoietic stem cell recipientsEuropean Journal of Haematology, 2005
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004
- Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialThe Lancet, 2004
- Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile NeutropeniaClinical Infectious Diseases, 2001
- Procalcitonin – a new marker of severe infection and sepsisIntensive Care Medicine, 2000
- SERUM LEVELS OF INTERLEUKIN 6, INTERLEUKIN 8, AND C-REACTIVE PROTEIN AFTER HUMAN ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1994